Global and China Peripheral Intervention Drug-Eluting Devices Market Insights, Forecast to 2026

Global and China Peripheral Intervention Drug-Eluting Devices Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Market Segments
1.3 Key Peripheral Intervention Drug-Eluting Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
1.4.2 Plain Old Balloon Angioplasty (POBA)
1.4.3 Percutaneous Transluminal Angioplasty (PTA)
1.5 Market by Application
1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
1.5.2 Drug-Eluting Balloons
1.5.3 Drug-Eluting Stents
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size, Estimates and Forecasts
2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2015-2026
2.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2015-2026
2.2 Global Peripheral Intervention Drug-Eluting Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Peripheral Intervention Drug-Eluting Devices Historical Market Size by Region (2015-2020)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2021-2026)
2.4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026)
3 Global Peripheral Intervention Drug-Eluting Devices Competitor Landscape by Players
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers (2015-2020)
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2020)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peripheral Intervention Drug-Eluting Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
3.2.5 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
3.4 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution, Product Types
3.4.1 Peripheral Intervention Drug-Eluting Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
3.4.3 Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2015-2020)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)
4.1.3 Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Peripheral Intervention Drug-Eluting Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
4.2.3 Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application (2015-2020)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2015-2020)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2015-2020)
5.1.3 Peripheral Intervention Drug-Eluting Devices Price by Application (2015-2020)
5.2 Peripheral Intervention Drug-Eluting Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
6.1.1 China Peripheral Intervention Drug-Eluting Devices Sales YoY Growth 2015-2026
6.1.2 China Peripheral Intervention Drug-Eluting Devices Revenue YoY Growth 2015-2026
6.1.3 China Peripheral Intervention Drug-Eluting Devices Market Share in Global Market 2015-2026
6.2 China Peripheral Intervention Drug-Eluting Devices Market Size by Players (International and Local Players)
6.2.1 China Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2015-2020)
6.2.2 China Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2015-2020)
6.3 China Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2015-2020)
6.3.1 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
6.3.2 China Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
6.3.3 China Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)
6.4 China Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2021-2026)
6.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
6.4.3 China Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
6.5 China Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2015-2020)
6.5.1 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
6.5.2 China Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
6.5.3 China Peripheral Intervention Drug-Eluting Devices Price by Application (2015-2020)
6.6 China Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2021-2026)
6.6.2 China Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
6.6.3 China Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2021-2026)
7 North America
7.1 North America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
7.2 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
7.2.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2015-2020)
7.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
8.2 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
8.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country
8.2.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
9.2.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2015-2020)
9.2.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
10.2 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
10.2.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country
10.2.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country
11.2.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Medtronic plc
12.1.1 Medtronic plc Corporation Information
12.1.2 Medtronic plc Description and Business Overview
12.1.3 Medtronic plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.1.5 Medtronic plc Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Corporation Information
12.2.2 Boston Scientific Corporation Description and Business Overview
12.2.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Corporation Information
12.3.2 Abbott Laboratories Description and Business Overview
12.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Cardinal Health
12.4.1 Cardinal Health Corporation Information
12.4.2 Cardinal Health Description and Business Overview
12.4.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
12.4.5 Cardinal Health Recent Development
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Corporation Information
12.5.2 B. Braun Melsungen AG Description and Business Overview
12.5.3 B. Braun Melsungen AG Sales, Revenue and Gross Margin (2015-2020)
12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
12.5.5 B. Braun Melsungen AG Recent Development
12.6 Biosensors International Group Ltd.
12.6.1 Biosensors International Group Ltd. Corporation Information
12.6.2 Biosensors International Group Ltd. Description and Business Overview
12.6.3 Biosensors International Group Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
12.6.5 Biosensors International Group Ltd. Recent Development
12.7 C.R. Bard, Inc.
12.7.1 C.R. Bard, Inc. Corporation Information
12.7.2 C.R. Bard, Inc. Description and Business Overview
12.7.3 C.R. Bard, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
12.7.5 C.R. Bard, Inc. Recent Development
12.8 Abbott
12.8.1 Abbott Corporation Information
12.8.2 Abbott Description and Business Overview
12.8.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
12.8.5 Abbott Recent Development
12.9 The Lubrizol Corporation
12.9.1 The Lubrizol Corporation Corporation Information
12.9.2 The Lubrizol Corporation Description and Business Overview
12.9.3 The Lubrizol Corporation Sales, Revenue and Gross Margin (2015-2020)
12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.9.5 The Lubrizol Corporation Recent Development
12.10 Terumo Corporation
12.10.1 Terumo Corporation Corporation Information
12.10.2 Terumo Corporation Description and Business Overview
12.10.3 Terumo Corporation Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.10.5 Terumo Corporation Recent Development
12.11 Medtronic plc
12.11.1 Medtronic plc Corporation Information
12.11.2 Medtronic plc Description and Business Overview
12.11.3 Medtronic plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.11.5 Medtronic plc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Peripheral Intervention Drug-Eluting Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Peripheral Intervention Drug-Eluting Devices Market Segments
Table 2. Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Plain Old Balloon Angioplasty (POBA)
Table 5. Major Manufacturers of Percutaneous Transluminal Angioplasty (PTA)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Peripheral Intervention Drug-Eluting Devices Sales by Regions 2015-2020 (K Units)
Table 9. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Regions (2015-2020)
Table 10. Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers (2015-2020)
Table 14. Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
Table 16. Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Peripheral Intervention Drug-Eluting Devices Price (2015-2020) (USD/Unit)
Table 19. Peripheral Intervention Drug-Eluting Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table 21. Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2015-2020) (K Units)
Table 24. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2015-2020)
Table 25. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)
Table 27. Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2021-2026)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2015-2020) (K Units)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2015-2020)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2021-2026)
Table 32. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) of Key Companies (2015-2020)
Table 36. China Peripheral Intervention Drug-Eluting Devices Sales Share by Company (2015-2020)
Table 37. China Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Company (2015-2020)
Table 38. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2015-2020)
Table 39. China Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2015-2020)
Table 40. China Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Peripheral Intervention Drug-Eluting Devices Price (K Units) by Type (2015-2020)
Table 42. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2021-2026)
Table 43. China Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2021-2026)
Table 44. China Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2021-2026)
Table 46. China Peripheral Intervention Drug-Eluting Devices Price (K Units) by Type (2021-2026)
Table 47. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2015-2020)
Table 48. China Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2015-2020)
Table 49. China Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2021-2026)
Table 51. China Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2021-2026)
Table 52. China Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2021-2026)
Table 54. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2015-2020) (K Units)
Table 55. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2015-2020)
Table 56. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2015-2020)
Table 58. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2015-2020) (K Units)
Table 59. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2015-2020)
Table 60. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
Table 66. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2015-2020) (K Units)
Table 67. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2015-2020)
Table 74. Medtronic plc Corporation Information
Table 75. Medtronic plc Description and Business Overview
Table 76. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 78. Medtronic plc Recent Development
Table 79. Boston Scientific Corporation Corporation Information
Table 80. Boston Scientific Corporation Description and Business Overview
Table 81. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Boston Scientific Corporation Product
Table 83. Boston Scientific Corporation Recent Development
Table 84. Abbott Laboratories Corporation Information
Table 85. Abbott Laboratories Description and Business Overview
Table 86. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Recent Development
Table 89. Cardinal Health Corporation Information
Table 90. Cardinal Health Description and Business Overview
Table 91. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Cardinal Health Product
Table 93. Cardinal Health Recent Development
Table 94. B. Braun Melsungen AG Corporation Information
Table 95. B. Braun Melsungen AG Description and Business Overview
Table 96. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. B. Braun Melsungen AG Product
Table 98. B. Braun Melsungen AG Recent Development
Table 99. Biosensors International Group Ltd. Corporation Information
Table 100. Biosensors International Group Ltd. Description and Business Overview
Table 101. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Biosensors International Group Ltd. Product
Table 103. Biosensors International Group Ltd. Recent Development
Table 104. C.R. Bard, Inc. Corporation Information
Table 105. C.R. Bard, Inc. Description and Business Overview
Table 106. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. C.R. Bard, Inc. Product
Table 108. C.R. Bard, Inc. Recent Development
Table 109. Abbott Corporation Information
Table 110. Abbott Description and Business Overview
Table 111. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Abbott Product
Table 113. Abbott Recent Development
Table 114. The Lubrizol Corporation Corporation Information
Table 115. The Lubrizol Corporation Description and Business Overview
Table 116. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. The Lubrizol Corporation Product
Table 118. The Lubrizol Corporation Recent Development
Table 119. Terumo Corporation Corporation Information
Table 120. Terumo Corporation Description and Business Overview
Table 121. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Terumo Corporation Product
Table 123. Terumo Corporation Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Peripheral Intervention Drug-Eluting Devices Players
Table 128. Peripheral Intervention Drug-Eluting Devices Customers List
Table 129. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Plain Old Balloon Angioplasty (POBA) Product Picture
Figure 4. Percutaneous Transluminal Angioplasty (PTA) Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020 & 2026
Figure 6. Drug-Eluting Balloons
Figure 7. Drug-Eluting Stents
Figure 8. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Market Size 2015-2026 (US$ Million)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Sales 2015-2026 (K Units)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region in 2019
Figure 14. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
Figure 15. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region in 2019
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
Figure 18. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
Figure 20. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2019
Figure 21. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
Figure 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type in 2019
Figure 23. Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Range (2015-2020)
Figure 24. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
Figure 25. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2019
Figure 26. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
Figure 27. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application in 2019
Figure 28. China Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2015-2026 (K Units)
Figure 29. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. China Peripheral Intervention Drug-Eluting Devices Market Share in Global Market 2015-2026
Figure 31. China 5 and 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue in Peripheral Intervention Drug-Eluting Devices in 2019
Figure 32. China Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)
Figure 33. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 34. China Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2015-2020)
Figure 35. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2019
Figure 39. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2019
Figure 40. U.S. Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Peripheral Intervention Drug-Eluting Devices Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country in 2019
Figure 47. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country in 2019
Figure 48. Germany Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Peripheral Intervention Drug-Eluting Devic

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs